Novel emerging therapy for erectile dysfunction: efficacy and safety of flat magnetic stimulation.
| Autor: | Galimberti D; Coordinador de Láser de Derma Internacional Centre, Buenos Aires. daniel.galimberti@gmail.com., Vila Echague A; Médica Dermatologa, Directora de Grupo de Láser SAD (Sociedad Argentina de Dermatología), Buenos Aires. agus1511@yahoo.com., Ko EA; Dermatóloga, Fellow de Láser y Estética Derma Internacional, Buenos Aires. erykohiba@gmail.com., Pieri L; El.En. Group, Calenzano. l.pieri@deka.it., Comito A; El.En. Group, Calenzano. a.comito@elen.it., Fusco I; El.En. Group, Calenzano. i.fusco@deka.it., Zingoni T; El.En. Group, Calenzano. t.zingoni@elen.it. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica [Arch Ital Urol Androl] 2024 May 06; Vol. 96 (2), pp. 12506. Date of Electronic Publication: 2024 May 06. |
| DOI: | 10.4081/aiua.2024.12506 |
| Abstrakt: | Background: The erectile dysfunction (ED), which is the inability to achieve and/or sustain a penile erection sufficient to result in a satisfying sexual performance, represents a very common complaint. for men over forty years old. The aim of the study was to evaluate if Flat Magnetic Stimulation (FMS) technology could help individuals with symptomatic erectile dysfunction. Methods: Twenty patients with erectile dysfunction, underwent eight sessions of about 30 minutes each in a twice a week frequency with the study device. During treatments, every potential side effect was assessed. The International Index of Erectile Function (IIEF) was compiled by all patients at the beginning, after the eighth treatment and at 1 month from the end of the last treatment. The questionnaire scores were presented as median values along with the interquartile range (IQR) and we set the significance threshold at 0.01. Results: After the treatment and at 1-month follow-up, the increase in questionnaire scores was statistically significant compared to the baseline, thus supporting the clinical usefulness of this treatment. In particular, the result of the study indicates a statistically significant difference between IIEF score before treatment (Median = 34) and IIEF score after the end of treatment (Median = 45) and between IIEF score before treatment and IIEF score at 1-month follow-up (Median = 54). Conclusions: The study findings showed that FMS represents a promising treatment option to individuals affected by symptomatic erectile dysfunction. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|